{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:46:07Z","timestamp":1788885967996,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,5,1]]},"DOI":"10.1038\/sj.bmt.1702995","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T15:42:22Z","timestamp":1032277342000},"page":"899-916","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Hematopoietic stem cell transplantation activity in Europe 1999"],"prefix":"10.1038","volume":"27","author":[{"given":"A","family":"Gratwohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Baldomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Urbano-Ispizua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the European Group for Blood and Marrow Transplantation (EBMT)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,7,2]]},"reference":[{"key":"BF1702995_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/bmj.321.7258.433","volume":"321","author":"AL Lennard","year":"2000","unstructured":"Lennard AL, Jackson GH . Stem cell transplantation Br Med J 2000 321: 433\u2013437","journal-title":"Br Med J"},{"key":"BF1702995_CR2","volume-title":"Hematopoietic Cell Transplantation, second edn","author":"SJ Forman","year":"1998","unstructured":"Forman SJ, Blume KG, Thomas ED (eds) . Hematopoietic Cell Transplantation, second edn Blackwell Scientific: London 1998"},{"key":"BF1702995_CR3","first-page":"197","volume":"8","author":"A Gratwohl","year":"1991","unstructured":"Gratwohl A . Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT) Bone Marrow Transplant 1991 8: 197\u2013201","journal-title":"Bone Marrow Transplant"},{"key":"BF1702995_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2796.1993.tb00681.x","volume":"233","author":"A Gratwohl","year":"1993","unstructured":"Gratwohl A, Hermans J, Goldman J, Gahrton G . Bone marrow transplantation in Europe. Major geographical differences J Int Med 1993 233: 333\u2013341","journal-title":"J Int Med"},{"key":"BF1702995_CR5","first-page":"5","volume":"13","author":"A Gratwohl","year":"1994","unstructured":"Gratwohl A, Hermans J . Bone marrow transplantation activity in Europe 1992. Report from the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 1994 13: 5\u201310","journal-title":"Bone Marrow Transplant"},{"key":"BF1702995_CR6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-0012.1995.tb00349.x","volume":"9","author":"A Gratwohl","year":"1995","unstructured":"Gratwohl A, Hermans J . Indications and donor source of hematopoietic stem cell transplants in Europe 1993 Clin Transplant 1995 9: 355\u2013363","journal-title":"Clin Transplant"},{"key":"BF1702995_CR7","first-page":"137","volume":"17","author":"A Gratwohl","year":"1996","unstructured":"Gratwohl A, Hermans J, Baldomero H . Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 1996 17: 137\u2013148","journal-title":"Bone Marrow Transplant"},{"key":"BF1702995_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/sj.bmt.1700694","volume":"19","author":"A Gratwohl","year":"1997","unstructured":"Gratwohl A, Hermans J, Baldomero H . Blood and marrow transplantation activity in Europe 1995 Bone Marrow Transplant 1997 19: 407\u2013419","journal-title":"Bone Marrow Transplant"},{"key":"BF1702995_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.bmt.1701329","volume":"22","author":"A Gratwohl","year":"1998","unstructured":"Gratwohl A . Blood and marrow transplantation activity in Europe 1996. Special report Bone Marrow Transplant 1998 22: 227\u2013240","journal-title":"Bone Marrow Transplant"},{"key":"BF1702995_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.bmt.1701866","volume":"24","author":"A Gratwohl","year":"1999","unstructured":"Gratwohl A, Passweg J, Baldomero H, Hermans J . Special report: blood and marrow transplantation activity in Europe 1997 Bone Marrow Transplant 1999 24: 231\u2013245","journal-title":"Bone Marrow Transplant"},{"key":"BF1702995_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/sj.thj.6200046","volume":"1","author":"A Gratwohl","year":"2000","unstructured":"Gratwohl A, Passweg J, Baldomero H et al. Hematopoietic stem cell transplantation in Europe 1998 Hematol J 2000 1: 333\u2013350","journal-title":"Hematol J"},{"issue":"4","key":"BF1702995_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1046\/j.1365-2141.1996.d01-1712.x","volume":"93","author":"Nigel Russell","year":"1996","unstructured":"Russell N, Gratwohl A, Schmitz N. Annotation: the place of blood stem cells in allogeneic transplantation . Br J Haematol 1996 93: 747\u2013753","journal-title":"British Journal of Haematology"},{"key":"BF1702995_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJM199708073370602","volume":"337","author":"E Gluckman","year":"1997","unstructured":"Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors New Engl J Med 1997 337: 373\u2013381","journal-title":"New Engl J Med"},{"key":"BF1702995_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma New Engl J Med 1995 333: 1540\u20131545","journal-title":"New Engl J Med"},{"key":"BF1702995_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"RA Zittoun","year":"1995","unstructured":"Zittoun RA, Mandellli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organisation for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell\u2019 Adulto (GIMEMA) Leukemia Cooperative Groups New Engl J Med 1995 332: 217\u2013223","journal-title":"New Engl J Med"},{"key":"BF1702995_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma New Engl J Med 1996 335: 91\u201397","journal-title":"New Engl J Med"},{"key":"BF1702995_CR17","first-page":"1165","volume":"34","author":"KK Matthay","year":"1996","unstructured":"Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group New Engl J Med 1996 34: 1165\u20131173","journal-title":"New Engl J Med"},{"key":"BF1702995_CR18","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJM200004133421508","volume":"342","author":"ME Lippmann","year":"2000","unstructured":"Lippmann ME . High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer New Engl J Med 2000 342: 1119\u20131120","journal-title":"New Engl J Med"},{"key":"BF1702995_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJM200004133421501","volume":"342","author":"EA Stadtmauer","year":"2000","unstructured":"Stadtmauer EA, O'Neill A, Goldstein LJ et al. Conventional-dose chemotherapy compared with high-dose chemotherapy autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group New Engl J Med 2000 342: 1069\u20131076","journal-title":"New Engl J Med"},{"key":"BF1702995_CR20","doi-asserted-by":"crossref","unstructured":"Chaos surrounds high-dose chemotherapy for breast cancer Lancet 1999 353: 1633","DOI":"10.1016\/S0140-6736(99)00085-9"},{"key":"BF1702995_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.bmt.1702597","volume":"26","author":"A Gratwohl","year":"2000","unstructured":"Gratwohl A, Baldomero H, Rosti G . High dose chemotherapy for breast cancer Bone Marrow Transplant 2000 26: 599","journal-title":"Bone Marrow Transplant"},{"key":"BF1702995_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1423-0410.1998.tb05438.x","volume":"2","author":"HJ Kolb","year":"1998","unstructured":"Kolb HJ . Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties Vox Sang 1998 2: : (Suppl.) 321","journal-title":"Vox Sang"},{"key":"BF1702995_CR23","first-page":"123","volume":"10","author":"A Gratwohl","year":"1999","unstructured":"Gratwohl A, Baldomero H, Hermans J . Quantitative assessment of consensus on indications for blood or marrow transplantation in Europe 1995 Cancer Res Ther Contr 1999 10: 123\u2013144","journal-title":"Cancer Res Ther Contr"},{"key":"BF1702995_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1023\/A:1008357107496","volume":"11 (Suppl. 1)","author":"RA Kyle","year":"2000","unstructured":"Kyle RA . The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy Ann Oncol 2000 11 (Suppl. 1): 55\u201358","journal-title":"Ann Oncol"},{"key":"BF1702995_CR25","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1995.13.10.2483","volume":"13","author":"WR Bezwoda","year":"1995","unstructured":"Bezwoda WR, Seymour I, Dansey RD . High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial J Clin Oncol 1995 13: 2483\u20132489","journal-title":"J Clin Oncol"},{"key":"BF1702995_CR26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/07357900009032816","volume":"18","author":"RD Baynes","year":"2000","unstructured":"Baynes RD, Dansey RD, Klein JL et al. High-dose chemotherapy and autologous stem cell transplantation for breast cancer Cancer Invest 2000 18: 440\u2013455","journal-title":"Cancer Invest"},{"key":"BF1702995_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/00062752-199704060-00008","volume":"4","author":"DL Confer","year":"1997","unstructured":"Confer DL . Unrelated marrow donor registries Curr Opin Hematol 1997 4: 408\u2013412","journal-title":"Curr Opin Hematol"},{"key":"BF1702995_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bmt.1702204","volume":"25","author":"AM Carella","year":"2000","unstructured":"Carella AM, Champlin R, Slavin S et al. Mini-allografts: ongoing trials in humans Bone Marrow Transplant 2000 25: 345\u2013350","journal-title":"Bone Marrow Transplant"},{"key":"BF1702995_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI9083","volume":"105","author":"BJ Druker","year":"2000","unstructured":"Druker BJ, Lydon NB . Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia J Clin Invest 2000 105: 3\u20137","journal-title":"J Clin Invest"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702995","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:01:35Z","timestamp":1733788895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,5,1]]}},"alternative-id":["BF1702995"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702995","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5,1]]},"assertion":[{"value":"13 September 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}